Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Hemoglobin Assay Performed with Photothermal Optical Sensor

By LabMedica International staff writers
Posted on 11 Jan 2015
An optical sensor, termed a photothermal spectral-domain optical coherence reflectometer (PT SD-OCR) is capable of direct measurement of hemoglobin concentration (Hb) without chemicals and preprocessing of blood.

The PT SD-OCR OCR measures Hb by quantifying refractive index changes of blood samples due to photothermal effect under the irradiation of 532-nm light and its diagnostic accuracy and precision has been evaluated in anemic patients.

Scientists at the Yonsei University (Seoul, Republic of Korea) and their colleagues used PT SD-OCR to measure Hb in 50 anemic patients, and examined its accuracy against a hematology analyzer. More...
Its precision was assessed by examining the standard deviation (SD) and coefficients of variation (CV) based on 20 repeated measurements on three blood sample and its performance was also compared with a hemoglobinometer.

The relative accuracy of the PT SD-OCR sensor was examined and the comparisons of the PT SD-OCR and HemoCue 201+ System (Angelholm, Sweden) against the results from the ADVIA 2120i hematology analyze (Siemens AG, Erlangen, Germany). An excellent correlation was observed between the results from the hematology analyzer and those of the PT SD-OCR sensor. The precision of the PT SD-OCR sensor was also comparable with the ADVIA 2120i analyzer and the HemoCue 201+ detector.

The authors concluded that simple and chemical-free operation of PT SD-OCR enabled rapid and accurate measurement of Hb in anemic patients. The sensor is expected to facilitate clinical procedures related to blood-related disorders in patient care. The PT SD-OCR sensor may therefore be readily utilized in clinical settings for hemoglobin detection and determination of proper treatment strategies for anemic patients. The study was published in the January 2015 issue of the journal Clinica Chimica Acta.

Related Links:

Yonsei University
HemoCue
Siemens AG 



New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
HPV Test
Allplex HPV28 Detection
New
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.